Table 2.

Logistic regression analysis for in-hospital outcomes in the increased FPG group compared with the increased HbA_1c group^a

	Unadjusted OR (95% CI)	P value	Adjusted OR (95% CI)b	P value
MACCE	1.94(1.13–3.34)	0.016	1.52(0.85–2.72)	0.158
Heart failure	2.09(1.42–3.07)	<  0.001	1.63(1.07–2.48)	0.024
Cardiovascular death or heart failure	2.11(1.44–3.07)	<  0.001	1.63(1.08–2.47)	0.021
MACCE or heart failure	1.98(1.41–2.79)	<  0.001	1.57(1.07–2.28)	0.020

^aA categorized variable to compare the increased FPG group with the increased HbA1c group was used in logistic regression analysis

^bORs were adjusted for age, gender, systolic blood pressure, heart rate, current smoker, hypertension, hemoglobin at admission, eGFR at admission, Killip class, type of acute coronary syndrome, glucose-lowering drug use, and β-blocker use during hospitalization

FPG Fasting plasma glucose, HbA_1c Glycosylated hemoglobin, MACCE Major adverse cardiovascular and cerebrovascular event